Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takaaki Masuda

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Patterns (New York, N.Y.)|April 25, 2022
Artificial intelligence-assisted drug repurposing via "chemical-induced gene expression ranking"Takaaki Masuda, Koshi Mimori
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Occult micrometastasis]Takaaki Masuda, Koshi Mimori, Masaki Mori
International Cancer Conference Journal|January 6, 2023
A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothoraxHirofumi Ohmura, Takaaki Masuda, Koshi Mimori, et al.
Molecular Oncology|February 23, 2016
Clinical and biological significance of circulating tumor cells in cancerTakaaki Masuda, Naoki Hayashi, Tomohiro Iguchi, et al.
International Journal of Biological Sciences|February 18, 2016
"DNA Binding Region" of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase CheckpointTakaaki Masuda, Xiaoling Xu, Emilios K Dimitriadis, et al.
The Breast Journal|December 5, 2020
A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancerTakaaki Masuda, Atsushi Nonami, Fumiaki Tanaka, et al.
Cancers|September 14, 2017
MicroRNAs as Biomarkers in Colorectal CancerTakaaki Masuda, Naoki Hayashi, Yosuke Kuroda, et al.
Surgery Today|April 2, 2021
Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrenceMitsuko Fukunaga, Koshi Mimori, Takaaki Masuda, et al.
International Journal of Pharmaceutics|November 15, 2011
Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovirTakaaki Masuda, Yasuo Yoshihashi, Etsuo Yonemochi, et al.
Cancer Science|January 21, 2020
Drug repositioning in cancer: The current situation in JapanTakaaki Masuda, Yusuke Tsuruda, Yoshihiro Matsumoto, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Patterns (New York, N.Y.)|April 25, 2022
Artificial intelligence-assisted drug repurposing via "chemical-induced gene expression ranking"Takaaki Masuda, Koshi Mimori
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Occult micrometastasis]Takaaki Masuda, Koshi Mimori, Masaki Mori
International Cancer Conference Journal|January 6, 2023
A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothoraxHirofumi Ohmura, Takaaki Masuda, Koshi Mimori, et al.
Molecular Oncology|February 23, 2016
Clinical and biological significance of circulating tumor cells in cancerTakaaki Masuda, Naoki Hayashi, Tomohiro Iguchi, et al.
International Journal of Biological Sciences|February 18, 2016
"DNA Binding Region" of BRCA1 Affects Genetic Stability through modulating the Intra-S-Phase CheckpointTakaaki Masuda, Xiaoling Xu, Emilios K Dimitriadis, et al.
The Breast Journal|December 5, 2020
A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancerTakaaki Masuda, Atsushi Nonami, Fumiaki Tanaka, et al.
Cancers|September 14, 2017
MicroRNAs as Biomarkers in Colorectal CancerTakaaki Masuda, Naoki Hayashi, Yosuke Kuroda, et al.
Surgery Today|April 2, 2021
Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrenceMitsuko Fukunaga, Koshi Mimori, Takaaki Masuda, et al.
International Journal of Pharmaceutics|November 15, 2011
Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovirTakaaki Masuda, Yasuo Yoshihashi, Etsuo Yonemochi, et al.
Cancer Science|January 21, 2020
Drug repositioning in cancer: The current situation in JapanTakaaki Masuda, Yusuke Tsuruda, Yoshihiro Matsumoto, et al.
Pageof 12